These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9374154)

  • 61. Hydroxyurea and lower leg ulcers.
    Nguyen TV; Margolis DJ
    Cutis; 1993 Oct; 52(4):217-9. PubMed ID: 8261806
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hydroxyurea induced non-healing leg ulcer.
    Prabhash K; Bapsy PP
    Indian J Dermatol Venereol Leprol; 2005; 71(1):50-2. PubMed ID: 16394367
    [No Abstract]   [Full Text] [Related]  

  • 63. A case of hydroxyurea-induced leg ulcer after definitive treatment suspension in a patient affected by thrombocythemia: effectiveness of a new collagenase.
    Fioramonti P; Fino P; Parisi P; Scuderi N; Onesti MG
    In Vivo; 2012; 26(6):1053-6. PubMed ID: 23160693
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Leg ulcers associated with hydroxyurea therapy.
    Sastre JL; Bravo A; Tembrás S; Gómez R; Ulibarrena C
    Haematologica; 2003 Feb; 88(2):EIM01. PubMed ID: 12604429
    [No Abstract]   [Full Text] [Related]  

  • 65. Chronic Myeloid Leukaemia with Sudden Bilateral Deafness and Leg Ulcer Associated with Hydroxyurea Therapy.
    Ugwu NI; Okoye AE; Ugwu CN; Ibiam FA; Nnachi OA; Ugwu GC; Okoh NU
    West Afr J Med; 2021 May; 38(5):502-506. PubMed ID: 34051725
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hydroxyurea dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea.
    Daoud MS; Gibson LE; Pittelkow MR
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):178-82. PubMed ID: 9039164
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hydroxyurea-induced onychomadesis in a dog with chronic myeloid leukemia: A case report.
    Anjos DSD; Costa PB; Magalhães LF; Sierra OR; Calazans SG; Fonseca-Alves CE
    Top Companion Anim Med; 2018 Sep; 33(3):73-76. PubMed ID: 30243362
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Leukemia, cytostatic therapy and pregnancy].
    Jakó J
    Orv Hetil; 1994 Jan; 135(1):43. PubMed ID: 7779171
    [No Abstract]   [Full Text] [Related]  

  • 69. [Multiple keratosis induced by hydroxyurea].
    Grange F; Couilliet D; Audhuy B; Krzisch S; Schlecht P; Guillaume JC
    Ann Dermatol Venereol; 1995; 122(1-2):16-8. PubMed ID: 7668775
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Severe hypersensitivity pneumonitis associated with anagrelide.
    Raghavan M; Mazer MA; Brink DJ
    Ann Pharmacother; 2003 Sep; 37(9):1228-31. PubMed ID: 12921504
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hydroxyurea-induced acute alveolitis in a patient with chronic myeloid leukaemia.
    Jackson GH; Wallis J; Ledingham J; Lennard A; Proctor SJ
    Cancer Chemother Pharmacol; 1990; 27(2):168-9. PubMed ID: 2249336
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Painful leg ulcers and a rash in a patient with polycythaemia rubra vera. Diagnosis: hydroxyurea-induced leg ulceration and dermatomyositis-like skin changes.
    Haniffa MA; Speight EL
    Clin Exp Dermatol; 2006 Sep; 31(5):733-4. PubMed ID: 16901329
    [No Abstract]   [Full Text] [Related]  

  • 73. Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption?
    Nofal A; El-Din ES
    Int J Dermatol; 2012 May; 51(5):535-41. PubMed ID: 22515579
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Cutaneous side effects of a long-term treatment by hydroxyurea].
    Steels E; Heenen M; Germaux MA; Moens JP
    Rev Med Brux; 2006; 27(1):39-41. PubMed ID: 16608010
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Limbal stem cell deficiency arising from systemic chemotherapy.
    Ellies P; Anderson DF; Topuhami A; Tseng SC
    Br J Ophthalmol; 2001 Mar; 85(3):373-4. PubMed ID: 11277104
    [No Abstract]   [Full Text] [Related]  

  • 76. Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related?
    Bader U; Banyai M; Böni R; Burg G; Hafner J
    Dermatology; 2000; 200(1):45-8. PubMed ID: 10681614
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
    Motomura S; Sakai R; Tomita N; Fujimaki K; Hattori M; Fujisawa S; Mohri H; Takahashi N; Maruta A; Kodama F; Okubo T
    Rinsho Ketsueki; 1998 Apr; 39(4):302-7. PubMed ID: 9597898
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hazards of interferon therapy in chronic granulocytic leukaemia.
    Jacobs P; Wood L
    S Afr Med J; 1997 Oct; 87(10):1394. PubMed ID: 9472263
    [No Abstract]   [Full Text] [Related]  

  • 79. Tumor lysis syndrome.
    Ezzone SA
    Semin Oncol Nurs; 1999 Aug; 15(3):202-8. PubMed ID: 10461705
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multiple skin tumors in long-term treatment with hydroxyurea.
    Stasi R; Cantonetti M; Abruzzese E; Papi M; Didona B; Cavalieri R; Papa G
    Eur J Haematol; 1992 Feb; 48(2):121-2. PubMed ID: 1547876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.